Gastropharm

Gastropharm is a specialized pharmaceutical company headquartered in St. Petersburg, Russia, dedicated to the development and production of gastroprotective therapeutics. The company is most recognized for its flagship drug, also named Gastropharm, which utilizes a unique formulation of dried Lactobacillus bulgaricus cells and their metabolic products. This medication is clinically indicated for the management of acute and chronic gastritis, as well as gastric and duodenal ulcers, by providing mucosal protection and promoting tissue regeneration. Gastropharm operates its own specialized manufacturing facilities that adhere to pharmaceutical standards for the production of probiotic-based medicines. Since its establishment in the mid-1990s, the company has maintained a significant presence in the gastroenterology market within Russia and several CIS countries. The company's focus remains on providing cost-effective, biological treatments for digestive disorders that bridge the gap between traditional probiotics and specialized pharmaceuticals.